N/A
Completed N=300
Translating Data Science to Palliative Care
Source: ClinicalTrials.gov NCT05942040 ↗Enrolled (actual)
300
Serious AEs
0.0%
Results posted
Nov 2025
Primary outcomePrimary: Palliative Care Refusal Rate — 50; 69; 61; 113 Participants — p=0.17
Summary
This research study is intended to 1) better understand seriously ill adults' and their family care partners' (FCP), particularly for persons living with dementia (PLwD), barriers to accepting community-based palliative care (CBPC); 2) develop an intervention to address barriers; and 3) pilot test whether the intervention has an impact on CBPC uptake. The intervention will consist of 1) a set of informational material describing the benefits of CBPC for the CBPC team to use when presenting CBPC to members of a Medicare Advantage plan and their FCP; and 2) processes for tailoring information delivery so that eligible members and their FCP receive information about CBPC that reflects their individualized risk as identified by the Medicare Advantage program's validated 12-month mortality risk algorithm.
The clinical trial portion of the study refers to the pilot test (Aim 3 as described below).
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Palliative Care Refusal Rate |
50; 69; 61; 113 | 0.17 |
| SECONDARY CBPC Team Members Satisfaction |
35; 47.5; 52 | — |
Eligibility Criteria
Inclusion Criteria
- VNS Health Total Medicare Advantage Plan member
- identified as eligible for community-based palliative care by the VNS Health Total palliative care team during the study period (6-month period prior to introduction of the intervention and the 6-month period following the intervention)
- 18 years of age or older
Exclusion Criteria
- non-VNS Health Total Medicare Advantage Plan member
- VNS Health Total plan members not identified as eligible for community-based palliative care by the palliative care team during the study period (6-month period prior to introduction of the intervention and the 6-month period following the intervention)
- under 18 years of age
Data sourced from ClinicalTrials.gov (NCT05942040). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.